High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have an increased prevalence of moderate and severe depressive and anxiety symptoms compared with control women, and do these symptoms correlate with age, BMI, testosterone, hirsutism or insulin resistance (IR)? SUMMARY ANSWER: Women with PCOS have significantly increased odds of moderate and severe depressive and anxiety symptoms, independent of obesity, and the symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism and IR. WHAT IS KNOWN ALREADY: Previous studies have reported that women with PCOS have an increased prevalence of mild depressive and anxiety symptoms or an increase in mean depression and anxiety scores, although these scores are usually within the normal range. Thus, it is therefore not clear whether these findings are clinically significant. The prevalence of moderate and severe depressive and anxiety symptoms, which require follow-up and would benefit from treatment, is not known in this population. STUDY DESIGN, SIZE, DURATION: A comprehensive systematic review (SR) was performed up to January 2016 and included 30 cross-sectional studies, representing 3050 subjects with PCOS and 3858 controls, from 10 different countries. The meta-analysis (MA) on depressive symptoms included 18 studies and the MA on anxiety symptoms included 9 studies. A separate SR identified 15 studies for the meta-regression examining the associations with PCOS-related symptoms or comorbidities. PARTICIPANTS/MATERIALS, SETTING, METHODS: All studies included adult women with PCOS, defined by the National Institutes of Health or Rotterdam criteria, and a control group without PCOS. Ovid, Embase, PsychInfo and Cochrane were searched up to January 2016. Included studies used a validated screening tool to compare the prevalence or mean scores of depressive and/or anxiety symptoms. Random effects MA was used to estimate the pooled odds ratio (OR) of depressive and anxiety symptoms. Sensitivity analyses of methodological characteristics and a meta-regression of the pooled standardized mean difference (SMD) to evaluate PCOS-related clinical and laboratory associations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS had increased odds of any depressive symptoms (OR: 3.78; 95% CI: 3.03-4.72; 18 studies) and of moderate/severe depressive symptoms (OR: 4.18; 95% CI: 2.68-6.52; 11 studies). Women with PCOS had increased odds of any anxiety symptoms (OR: 5.62; 95% CI: 3.22-9.80, nine studies) and of moderate/severe anxiety symptoms (OR: 6.55; 95% CI: 2.87, 14.93; five studies). When subjects were matched on BMI, women with PCOS still had higher odds of both depressive (OR: 3.25; 95% CI 1.73-6.09; four studies) and anxiety symptoms (OR: 6.30, 95% CI: 1.88-21.09; three studies). There was no substantial heterogeneity among studies in the overall MA on depressive symptoms (I2 = 22.4%, P = 0.19), but there was significant heterogeneity among studies in the analysis on anxiety symptoms (I2 = 59.6%, P= 0.01). In the meta-regression evaluating pooled SMDs between groups, women with PCOS and concurrent depression had higher mean values of age, BMI, hirsutism score and IR, while women with PCOS and concurrent anxiety had higher mean values of BMI, hirsutism score and free testosterone (P < 0.05 for all comparisons). LIMITATIONS, REASON FOR CAUTION: All studies were cross-sectional, thus we can only hypothesize that the diagnosis of PCOS precedes the diagnosis of depression and anxiety. There were large variations in methodological characteristics especially in the studies screening for anxiety; however, they only partly explained effect size variation. WIDER IMPLICATIONS OF THE FINDINGS: This evidence-synthesis analysis shows that PCOS diagnosis is associated with an increased risk of moderate and severe depressive and anxiety symptoms and suggests that providers should consider screening women with PCOS for both depression and anxiety. Although age, obesity, hyperandrogenism and IR do not explain the entire association, well-designed studies are needed to assess the impact of treatment of these factors on depressive and anxiety symptoms in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. There are no conflicts of interest. REGISTRATION NUMBER: N/A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is concerning given the established evidence of increased depression, anxiety, eating disorders and other mental illnesses in those affected with PCOS [3, 8, 57–59].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [58]
In the citing paper
“This prevalence of eating disorders is relatively high compared to that found in other population studies that report a 0.3%-2.45% prevalence in those with PCOS.31,126,129,130”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [129]
In the citing paper
“Another meta-analysis estimated a prevalence of 36 % for depression in PCOS [69].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [69]
In the citing paper
“The risk of developing depression may be associated with higher BMI [70], although this association is weak.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [70]
In the citing paper
“A recent meta-analysis of depression rates among women with PCOS resulted in a median prevalence of depression of almost 37% compared to 14% in controls [8].”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
Siu, A. L., and the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., et al. (2016) · JAMA · doi:10.1001/jama.2015.18392 · Cited by 1,407
Research works printed but not linked: 3
- 2014, Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome, Noropsikiyatri Arsivi, 51, 129
- 2013, Psychiatric symptoms in women with polycystic ovary syndrome, Dusunen Adam, 26, 157
- 1992, Polycystic ovary syndrome, 377
Cited by
Items 101–200 of 750
Greenwood, E. A., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.10.004 · Cited by 36
Silva, M. S. B., Decoster, L., Delpouve, G., Lhomme, T., Ternier, G., Prévot, V., & Giacobini, P. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104850 · Cited by 41
Ismayilova, M., & Yaya, S. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01734-w · Cited by 40
“Women with PCOS often struggle with menstrual irregularity [2], infertility [3], body image issues [4], eating disorders [5], hirsutism [6], acne [7], and anxiety and depression [8].”
Cognitive behavioural therapy for depression in women with PCOS: systematic review and meta-analysis
Jiskoot, G., van der Kooi, A.-L., Busschbach, J. J. V., Laven, J. S. E., & Beerthuizen, A. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.05.001 · Cited by 40
Rao, V. S., Cowan, S., Armour, M., Smith, C. A., Cheema, B. S., Moran, L., Lim, S. S., Gupta, S., de Manincor, M., Sreedhar, V., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315850 · Cited by 40
The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
Anala, A. D., Saifudeen, I. S. H., Ibrahim, M., Nanda, M., Naaz, N., & Atkin, S. L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144575 · Cited by 39
Ethirajulu, A., Alkasabera, A., Onyali, C. B., Anim-Koranteng, C., Shah, H. E., Bhawnani, N., & Mostafa, J. A. (2021) · Cureus · doi:10.7759/cureus.18013 · Cited by 39
The Role of m6A on Female Reproduction and Fertility: From Gonad Development to Ovarian Aging
Sun, X., Lu, J., Li, H., & Huang, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.884295 · Cited by 39
Amiri, F. N., Faramarzi, M., Omidvar, S., & Alizadeh‐Navaei, R. (2023) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2022-0065 · Cited by 39
Böttcher, B., Fessler, S., Friedl, F., Tóth, B., Walter, M. H., Wildt, L., & Riedl, D. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4623-2 · Cited by 40
Transtheoretical model-based mobile health application for PCOS
Wang, L., Liu, Y., Tan, H., & Huang, S. (2022) · Reproductive Health · doi:10.1186/s12978-022-01422-w · Cited by 38
Ismayilova, M., & Yaya, S. (2023) · International Health · doi:10.1093/inthealth/ihac028 · Cited by 38
Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
Baba, T. (2025) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12630 · Cited by 38
Integrated Model of Care for Polycystic Ovary Syndrome
Tay, C., Moran, L., Wijeyaratne, C., Redman, L., Norman, R., Teede, H., & Joham, A. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667310 · Cited by 29
Guo, Q.-J., Shan, J., Xu, Y., Hu, Y., Huo, C., Song, J., Wang, C., Zhou, H., Yu, C.-Q., & Huang, Q. (2020) · Mediators of Inflammation · doi:10.1155/2020/3050487 · Cited by 38
Stefanaki, K., Karagiannakis, D. S., Raftopoulou, M., Ψαλτοπούλου, Θ., Paschou, S. Α., & Ilias, Ι. (2023) · Endocrine · doi:10.1007/s12020-023-03436-1 · Cited by 38
The Psychosocial Impact of Polycystic Ovary Syndrome
Simon, V., Peigné, M., & Dewailly, D. (2023) · Reproductive Medicine · doi:10.3390/reprodmed4010007 · Cited by 37
Broadening horizons: the role of ferroptosis in polycystic ovary syndrome
Wang, M., Zhang, B.-Q., Ma, S., Xu, Y. J., Zhao, D.-H., Zhang, J., Li, C.-J., Zhou, X., & Zheng, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1390013 · Cited by 37
Body image and mental health in women with polycystic ovary syndrome–a cross-sectional study
Hofmann, K., Decrinis, C., Bitterlich, N., Tropschuh, K., Stute, P., & Bachmann, A. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07913-4 · Cited by 37
Longitudinal change instead of baseline testosterone predicts depressive symptoms
Kische, H., Pieper, L., Venz, J., Klotsche, J., März, W., Koch, U., Pittrow, D. B., Lehnert, H., Silber, S., Stalla, G. K., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.12.013 · Cited by 37
Approach to the Patient: Diagnostic Challenges in the Workup for Polycystic Ovary Syndrome
Joham, A. E., Tay, C. T., Laven, J. S. E., Louwers, Y. V., & Azziz, R. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae910 · Cited by 36
Weiss, M. S., Roe, A. H., Allison, K. C., Dodson, W. C., Kris‐Etherton, P. M., Kunselman, A. R., Stetter, C., Williams, N. I., Gnatuk, C. L., Estes, S. J., et al. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.08.1396 · Cited by 36
Self-citationGnawali, A., Patel, V., Cuello-Ramírez, A., kaabi, A. S. A., Noor, A., Rashid, M. Y., Henin, S., & Mostafa, J. A. (2021) · Cureus · doi:10.7759/cureus.13489 · Cited by 36
Jamilian, M., Foroozanfard, F., Kavossian, E., Aghadavod, E., Amirani, E., Mahdavinia, M., Mafi, A., & Asemi, Z. (2019) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2018.1557144 · Cited by 36
Ee, C., Smith, C., Moran, L., MacMillan, F., Costello, M., Baylock, B., & Teede, H. (2020) · BMC Women's Health · doi:10.1186/s12905-020-01090-7 · Cited by 35
Sukhapure, M., Eggleston, K., Douglas, K. M., Fenton, A. J., FRAMPTON, C. M. A., & Porter, R. (2021) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01158-9 · Cited by 35
Insights on the NF-κB system in polycystic ovary syndrome, attractive therapeutic targets
Tan, W., Zhang, J., Dai, F., Yang, D., Gu, R., Tang, L., Liu, H., & Cheng, Y. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04736-w · Cited by 34
Associations Between Anxiety, Body Mass Index, and Sex Hormones in Women
Staníková, D., Luck, T., Pabst, A., Bae, Y. J., Hinz, A., Glaesmer, H., Staník, J., Sacher, J., Engel, C., Enzenbach, C., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00479 · Cited by 34
Rzońca, E., Iwanowicz-Palus, G., Bień, A., Wdowiak, A., Szymański, R., & Chołubek, G. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15112484 · Cited by 34
Asselmann, E., Kische, H., Haring, R., Hertel, J., Schmidt, C.-O., Nauck, M., Beesdo-Baum, K., Grabe, H.-J., & Pané-Farré, C. A. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.052 · Cited by 28
Light, R. S., Chilcot, J., & McBride, E. (2021) · Women's Health Issues · doi:10.1016/j.whi.2020.11.003 · Cited by 33
Huddleston, H. G., Greenwood, E. A., Casaletto, K. B., Neuhaus, J. M., Kim, C., Wellons, M., Launer, L. J., & Yaffe, K. S. (2024) · Neurology · doi:10.1212/wnl.0000000000208104 · Cited by 33
Wei, Y., Lin, Z., Huang, Q., Wu, H., Wang, R., & Wang, J. (2025) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2025.2459618 · Cited by 33
Cutillas-Tolín, A., Árense-Gonzalo, J. J., Mendiola, J., Adoamnei, E., Navarro-Lafuente, F., Sánchez-Ferrer, M. L., Prieto‐Sánchez, M. T., Carmona‐Barnosi, A., Vioqué, J., & Torres-Cantero, A. M. (2021) · Nutrients · doi:10.3390/nu13020313 · Cited by 33
Effect of Dietary Regimen on the Development of Polycystic Ovary Syndrome: A Narrative Review
Alomran, S., & Estrella, E. D. (2023) · Cureus · doi:10.7759/cureus.47569 · Cited by 33
The impact of ageing and menopause in women with polycystic ovary syndrome
Helvaci, N., & Yildiz, B. O. (2022) · Clinical Endocrinology · doi:10.1111/cen.14558 · Cited by 32
Ask PCOS: identifying need to inform evidence-based app development for polycystic ovary syndrome
Xu, R., Gilbert, E., Kuczynska-Burggraf, M., Tan, B., Teede, H., Vincent, A., Gibson-Helm, M., & Boyle, J. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667187 · Cited by 32
Forslund, M., Melin, J., Alesi, S., Piltonen, T., Romualdi, D., Tay, C. T., Witchel, S., Pena, A., Mousa, A., & Teede, H. (2023) · Clinical Endocrinology · doi:10.1111/cen.14913 · Cited by 32
“Women with PCOS have higher BMI, are more prone to gain weight and also have an increased risk of psychiatric comorbidity.(36,37) In this systematic review involving women with PCOS T A B L E 2 (C o nt in ue d ) A d ve rs e ef fe ct s”
BackgroundLi, G., Hu, J., Zhang, S., Fan, W., Wen, L., Wang, G., & Zhang, D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.603279 · Cited by 32
Dubé‐Zinatelli, E., Anderson, F., & Ismail, N. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101203 · Cited by 32
Polycystic ovary syndrome in 2025—insights and innovations
Dokras, A. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.09.025 · Cited by 32
Self-citationSchoretsanitis, G., Gastaldon, C., Kalaitzopoulos, D. R., Ochsenbein‐Kölble, N., Barbui, C., & Seifritz, E. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.044 · Cited by 31
Comprehensive transition of care for polycystic ovary syndrome from adolescence to adulthood
Simon, S. L., Phimphasone‐Brady, P., McKenney, K. M., Gulley, L. D., Bonny, A. E., Moore, J. M., Torres-Zegarra, C., & Cree‐Green, M. (2024) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(24)00019-1 · Cited by 30
Hartanti, M. D., Rosario, R., Hummitzsch, K., Bastian, N. A., Hatzirodos, N., Bonner, W. M., Bayne, R. A. L., Irving‐Rodgers, H. F., Anderson, R. A., & Rodgers, R. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229351 · Cited by 30
Bell, R. J., Islam, R. M., Skiba, M. A., Herbert, D., García, A., & Davis, S. R. (2021) · Human Reproduction · doi:10.1093/humrep/deab232 · Cited by 30
Zhang, S., He, H., Wang, Y., Wang, X., & Liu, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-34746-z · Cited by 30
Stress and polycystic ovarian syndrome-a case control study among Indian women
Benjamin, J. J., Kuppusamy, M., Radha, V., Rajamani, K., Puttaswamy, N., Koshy, T., Maruthy, K. N., & Padmavathi, R. (2023) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2023.101326 · Cited by 30
Origins and Impact of Psychological Traits in Polycystic Ovary Syndrome
Stener‐Victorin, E., Manti, M., Fornes, R., Risal, S., Lu, H., & Benrick, A. (2019) · Medical Sciences · doi:10.3390/medsci7080086 · Cited by 30
Głowińska, A., Dulęba, A. J., Zielona–Jenek, M., Siakowska, M., Pawelczyk, L. A., & Banaszewska, B. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00061-0 · Cited by 30
Pirotta, S., Joham, A., Grieger, J. A., Tay, C. T., Bahri-Khomami, M., Lujan, M., Lim, S. S., & Moran, L. J. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1726866 · Cited by 29
Fu, L.-W., Gao, Z., Zhang, N., Yang, N., Long, H.-Y., Kong, L.-Y., & Li, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117698 · Cited by 29
Cardiovascular contributions to dementia: Examining sex differences and female‐specific factors
Alexander, M. W., Paterson, J., Arvanitakis, Z., Black, S. E., Casaletto, K. B., Christakis, M. K., Einstein, G., Galea, L. A. M., Harwood, L., Kirkham, A. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70610 · Cited by 29
Depression in Girls With Obesity and Polycystic Ovary Syndrome and/or Type 2 Diabetes
Benson, J., Severn, C., Hudnut‐Beumler, J., Simon, S. L., Walders‐Abramson, N., Shomaker, L. B., Gulley, L. D., Taylor, A., Kelsey, M. M., Nadeau, K. J., et al. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.05.015 · Cited by 29
Tauqir, S., Israr, M., Rauf, B., Malik, M. O., Habib, S. H., Shah, F. A., Usman, M., Raza, M. A., Shah, I., Badshah, H., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01789-5 · Cited by 29
Aljefri, Y. E., Alahmadi, R. A., Alajmi, R. S., Alkhamisi, T. A., Maaddawi, H. A., Alraddadi, A., & Alamri, A. M. (2021) · Cureus · doi:10.7759/cureus.20593 · Cited by 29
Hassan, S., Shah, M., Malik, M. O., Ehtesham, E., Habib, S. H., & Rauf, B. (2022) · Endocrine · doi:10.1007/s12020-022-03198-2 · Cited by 29
Asdaq, S. M. B., & Yasmin, F. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.086 · Cited by 28
Yang, Y., Deng, H., Tian, L., Xia, M., Liu, C., Bu, X., Li, H., Fu, L., & Zhong, Z. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.084 · Cited by 28
Possible cognition changes in women with polycystic ovary syndrome: a narrative review
Naz, M. S. G., Rahnemaei, F. A., Tehrani, F. R., Sayehmiri, F., Ghasemi, V., Banaei, M., & Ozgoli, G. (2023) · Obstetrics & Gynecology Science · doi:10.5468/ogs.22165 · Cited by 28
Lee, I. T., Rees, J., King, S., Kim, A. E., Cherlin, T., Hinkle, S. N., Mumford, S. L., & Dokras, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae256 · Cited by 28
Self-citationÖberg, E., Lundell, C., Blomberg, L., Gidlöf, S. B., Egnell, P. T., & Hirschberg, A. L. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0066 · Cited by 28
Naumova, I., Castelo‐Branco, C., & Casals, G. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00546-x · Cited by 28
Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess
Silva, M. S. B., & Campbell, R. E. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210025 · Cited by 27
Altuntaş, S. Ç., Celik, O., Özer, Ü., & Çolak, S. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2118708 · Cited by 27
Silva, M. S. B., Decoster, L., Trova, S., Mimouni, N. E. H., Delli, V., Chachlaki, K., Yu, Q., Boehm, U., Prévot, V., & Giacobini, P. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203503119 · Cited by 27
Development of a question prompt list for women with polycystic ovary syndrome
Khan, N. N., Vincent, A., Boyle, J. A., Burggraf, M., Pillay, M., Teede, H., & Gibson-Helm, M. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.028 · Cited by 23
Keeratibharat, P., Sophonsritsuk, A., Saipanish, R., Wattanakrai, P., Anantaburana, M., & Tantanavipas, S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06154-8 · Cited by 26
Psychological experiences of adolescent girls with polycystic ovary syndrome: A qualitative study
Noroozi, M., Ekramzadeh, M., Hajivandi, L., & Mostafavi, F. (2020) · Iranian Journal of Nursing and Midwifery Research · doi:10.4103/ijnmr.ijnmr_276_19 · Cited by 25
Berni, T. R., Morgan, C. L., & Rees, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae518 · Cited by 25
dos Santos, Í. K., Pichini, G. S., Ferreira, C. D. D. M. L., Dantas, P. B., Browne, R. A. V., de Queirós, V. S., Soares, G. M., Gonçalves, A. K., Cabral, B. G. D. A. T., Maranhão, T. M. D. O., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.948414 · Cited by 25
Infante-Cano, M., García‐Muñoz, C., Matias-Soto, J., Pineda-Escobar, S., Villar-Alises, O., & Martínez-Calderón, J. (2024) · Archives of Women s Mental Health · doi:10.1007/s00737-024-01526-1 · Cited by 24
Ee, C., Smith, C. A., Costello, M., MacMillan, F., Moran, L., Baylock, B., & Teede, H. J. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2358-7 · Cited by 24
Chromium supplements in health and disease
Costello, R. B., Dwyer, J. T., & Merkel, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64121-2.00007-6 · Cited by 24
Depression, anxiety and self-esteem in adolescent girls with polycystic ovary syndrome
Zachurzok, A., Pasztak-Opiłka, A., & Gawlik, A. (2021) · Ginekologia Polska · doi:10.5603/gp.a2021.0042 · Cited by 24
Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone
Standeven, L. R., Olson, E. M., Leistikow, N., Payne, J. L., Osborne, L. M., & Hantsoo, L. V. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01244-w · Cited by 24
Jiskoot, G., de Loos, A. D., Timman, R., Beerthuizen, A., Laven, J., & Busschbach, J. (2022) · Journal of Eating Disorders · doi:10.1186/s40337-022-00593-y · Cited by 23
Kabiri, S. S., Javanbakht, Z., Zangeneh, M., Moludi, J., Saber, A., Salimi, Y., Tandorost, A., & Jamalpour, M. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524001168 · Cited by 23
Alamri, A. S., Alhomrani, M., Alsanie, W. F., Almuqbil, M. S., Alqarni, K. M., Alshehri, S. M., Abdulaziz, O., Salih, M. M., Raafat, B. M., Alamri, A., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.999813 · Cited by 23
Mazloomi, S., Mousavi, V., Aghadavod, E., & Mafi, A. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230110151155 · Cited by 23
Pehlivan, M., Sherman, K. A., Wuthrich, V. M., Gandhi, E., Zagic, D., Kopp, E., & Perica, V. (2023) · Health Psychology Review · doi:10.1080/17437199.2023.2245020 · Cited by 23
Khan, A. Y. R., Abdullah, M. A. K., Gul, R., Bhutta, H. R., Imran, M., Mazhar, S. B., & Tariq, N. (2024) · Cureus · doi:10.7759/cureus.52540 · Cited by 23
Joshi, R., Sawant, N., & Mayadeo, N. (2021) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-021-01505-x · Cited by 23
Day, F. R., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A. W., Kraft, P. L., Lin, N., Huang, H., Broer, L., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008517 · Cited by 23
Scannell, N., Villani, A. M., Moran, L., Mantzioris, E., & Cowan, S. (2025) · Nutrients · doi:10.3390/nu17071105 · Cited by 22
Ma, R., Zou, Y., Wang, W., Zheng, Q., Feng, Y., Dong, H., Tan, Z., Zeng, X., Zhao, Y., Deng, Y., et al. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00848-w · Cited by 22
Liu, Y., Shi, X., Xu, B., Wang, Z., Chen, Y., & Deng, M. (2023) · Biomedical Reports · doi:10.3892/br.2023.1674 · Cited by 22
Symptom profiles of women at risk of mood disorders: A latent class analysis
Weiss, S. J., Flynn, H. A., Christian, L. M., Hantsoo, L. V., di Scalea, T. L., Kornfield, S. L., Muzik, M., Simeonova, D. I., Cooper, B. A., Strahm, A. M., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.013 · Cited by 22
Akintoye, O. O., Ajibare, A. J., & Omotuyi, O. I. (2023) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2022.12.020 · Cited by 21
PCOS health-related quality-of-life and depressive symptoms across the lifespan: Comparative study
Wright, P. J., Tavakoli, A. S., & Corbett, C. F. (2023) · Journal of Women & Aging · doi:10.1080/08952841.2023.2230112 · Cited by 21
Dokras, A., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2025) · Reproduction · doi:10.1530/rep-25-0118 · Cited by 21
Self-citationPark, H.-R., Kim, J.-H., Lee, D., & Jo, H.-G. (2019) · Medicine · doi:10.1097/md.0000000000017321 · Cited by 21
DHEA and polycystic ovarian syndrome: Meta-analysis of case-control studies
Benjamin, J. J., Kuppusamy, M., Koshy, T., Maruthy, K. N., & Padmavathi, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261552 · Cited by 21
Geller, S., Levy, S., & Avitsur, R. (2025) · Health Psychology Open · doi:10.1177/20551029251327441 · Cited by 20
The role of sleep in PCOS: what we know and what to consider in the future
Teo, P., Henry, B. A., Moran, L., Cowan, S., & Bennett, C. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2082941 · Cited by 20
Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives
Xu, Y., Zhou, Z., Pan, J., & Huang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936948 · Cited by 20
Jeon, G. (2023) · Nutrients · doi:10.3390/nu16010096 · Cited by 20
Masoudi, M., Ansari, S., Kashani, L., Tavolinejad, H., Rashidi, B. H., Esalatmanesh, S., Ghazizadeh‐Hashemi, M., Noorbala, A. A., & Akhondzadeh, S. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000367 · Cited by 20
Jiang, X., Deng, Q., & Stener‐Victorin, E. (2021) · Human Reproduction · doi:10.1093/humrep/deab119 · Cited by 20
Alahmadi, A. A., Alahmadi, B. A., Wahman, L. F., & El‐Shitany, N. A. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.06.066 · Cited by 20
A population-based follow-up study shows high psychosis risk in women with PCOS
Karjula, S., Arffman, R. K., Morin-Papunen, L. C., Franks, S., Järvelin, M., Tapanainen, J. S., Miettunen, J., & Piltonen, T. (2021) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01195-4 · Cited by 20
Metadata
- Authors
- Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A.
- Affiliations
- Hospital of the University of Pennsylvania (US)
- Corresponding author
- Cooney, Laura G.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-09
- Volume
- 32
- Issue
- 5
- Pages
- 1075-1091
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2592269563
- Cited by
- 631
- References
- 80
- Citations by year
- 2026: 95 · 2025: 94 · 2024: 63 · 2023: 81 · 2022: 70 · 2021: 77 · 2020: 56 · 2019: 49 · 2018: 35 · 2017: 10
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- polycystic ovary syndrome, depressive symptoms, anxiety symptoms, depression prevalence, anxiety prevalence, obesity, insulin resistance, testosterone, hirsutism, body mass index, age, women's mental health, comorbidities, Rotterdam criteria, NIH criteria, screening tool, meta-regression, standardized mean difference
- MeSH terms
- Anxiety, Depression, Female, Humans, Polycystic Ovary Syndrome, Severity of Illness Index, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.